SAN DIEGO, CA--(Marketwire - September 06, 2011) - SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, today announced it will participate in Rodman & Renshaw Annual Global Investment Conference. The Company is scheduled to present in the North Foyer at the Waldorf-Astoria Hotel in New York City from 4:55pm to 5:20pm on Tuesday, September 13th.
During the conference, management will be available to meet with analysts, portfolio managers and investors. Interested parties who wish to meet with SpectraScience’s management may contact Rodman & Renshaw directly. Participation in the conference is by invitation only.
Michael Oliver, CEO of SpectraScience, said that, “The Rodman & Renshaw Conference is a great opportunity for the Company to showcase its upcoming WavSTAT 4 Optical Biopsy System introduction and future prospects in the medical device sector and to further our efforts to gain additional exposure. With more than 4,000 attendees (including private equity funds, institutional investors, sophisticated private investors and company executives), the Rodman & Renshaw Conference will provide the Company with new opportunities to attract new and greater interest in our efforts toward building a leading medical device technologies company.”
About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.
Contact:
SpectraScience, Inc.
Jim Dorst
Chief Financial Officer
(858) 405-9933
